## HUBB: Hubbell Incorporated - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 2.37 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($425.82)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. HM Payson & Co. Sells 37,095 Shares of Hubbell Inc $HUBB**
- Source: MarketBeat | 20251229T120825 | Somewhat-Bullish | Relevance: 100%
- HM Payson & Co. significantly reduced its stake in Hubbell Inc. by 19.6% in Q3, selling over 37,000 shares and now holding 0.29% of the company's stock valued at $65.41 million. This comes as insider sales were also reported, with two executives selling shares in early November. Despite these sales, Hubbell demonstrated strong operational performance, beating Q3 EPS estimates, providing positive FY2025 guidance, and increasing its quarterly dividend.

**2. Hubbell Inc $HUBB Stock Holdings Reduced by Boston Trust Walden Corp**
- Source: MarketBeat | 20251229T102043 | Somewhat-Bullish | Relevance: 100%
- Boston Trust Walden Corp decreased its stake in Hubbell Inc (NYSE:HUBB) by 4.9% during the third quarter, reducing its holding to 350,616 shares. Despite this reduction, Hubbell remains the 11th largest holding for the fund, representing 1.1% of its portfolio. Other institutional investors like Vanguard Group Inc., State Street Corp, Invesco Ltd., Geode Capital Management LLC, and Impax Asset Management Group plc increased their positions in Hubbell during the second quarter.

**3. Mirova US LLC Has $208.77 Million Stock Holdings in Hubbell Inc $HUBB**
- Source: MarketBeat | 20251230T130812 | Bullish | Relevance: 99%
- Mirova US LLC significantly increased its stake in Hubbell Inc. (NYSE:HUBB) by 42.2% in Q3, now holding 485,165 shares valued at $208.77 million. Hubbell reported strong Q3 EPS of $5.17, exceeding estimates, and raised its quarterly dividend to $1.42 per share. The company maintains an average analyst rating of "Moderate Buy" with a consensus target price of $488.43.

**4. 3 Reasons Investors Love Hubbell (HUBB)**
- Source: TradingView â€” Track All Markets | 20251230T040757 | Bullish | Relevance: 96%
- Hubbell (HUBB), a key player in the electrical products market, has shown strong financial performance, making it attractive to investors. The company's operating margin has risen by 7.6 percentage points over the last five years, and its EPS grew at an impressive 18.1% compounded annual growth rate. Additionally, Hubbell's free cash flow margin has expanded by 6.4 percentage points, highlighting its financial strength.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Evercore ISI Gr | $575 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Evercore ISI Gr | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.27M) |
| Sells | 3 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.6%)
- Blackrock Inc.: 8.8% (-6.9%)
- State Street Corpora: 4.3% (+3.6%)
- Bank Of New York Mel: 4.2% (-10.9%)
- JPMORGAN CHASE & CO: 3.3% (+69.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.37 elevated, pricing in significant growth expectations. Forward P/E 22.6x stretched relative to 9% growth. Quality metrics strong (ROE 25%, margin 15%). Insider selling cluster ($1.5M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $23.7B |
| Beta | 1.00 |
| 52W Range | $299.43 - $484.26 |
| Short Interest | 5.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.37 |
| Forward P/E | 22.6 |
| Current P/E | 24.6 |
| YoY Growth | 8.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.0% to -0.3% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.87), confirming momentum. RSI neutral at 52. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.31% (CS: 50) | Neutral |
| RSI_14 | 52.2 | Neutral |
| MACD Histogram | 0.87 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.009x | Above |
| vs SMA200 | 1.091x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $446.60
- **Stop Loss:** $425.82 (4.7% risk)
- **Target:** $467.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 63
- **Position Value:** $28,135.80
- **Portfolio %:** 28.14%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-03 (Est: $4.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.98 | $5.17 | +3.9% |
| 2025Q2 | $4.40 | $4.93 | +12.1% |
| 2025Q1 | $3.72 | $3.50 | -6.0% |
| 2024Q4 | $4.02 | $4.10 | +2.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*